Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000584902 | SCV000692983 | uncertain significance | not provided | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000845266 | SCV001004668 | likely benign | Hereditary spastic paraplegia 4 | 2024-12-03 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000845266 | SCV001301529 | uncertain significance | Hereditary spastic paraplegia 4 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Gene |
RCV000584902 | SCV001790181 | likely benign | not provided | 2020-09-25 | criteria provided, single submitter | clinical testing | Identified in an adult with pure HSP who also harbored a nonsense variant. Authors predict P45Q may act as a phenotype modifier when occurring in the presence of another spastin mutation (McDermott et al., 2006); Reported previously in multiple members of one family (Svenson et al., 2004). Two of the family members were affected with hereditary spastic paraplegia and two of the family members were asymptomatic (Svenson et al., 2004); This variant is associated with the following publications: (PMID: 30834979, 16832076, 20301339, 19730024, 15248095) |
Genome Diagnostics Laboratory, |
RCV001847588 | SCV002105599 | uncertain significance | Hereditary spastic paraplegia | 2019-03-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV004998076 | SCV005621756 | likely benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000006026 | SCV000026208 | risk factor | Spastic paraplegia 4, modifier of | 2004-09-01 | no assertion criteria provided | literature only | |
Gene |
RCV000845266 | SCV000987270 | not provided | Hereditary spastic paraplegia 4 | no assertion provided | literature only |